|分野（sector）||Health Care ヘルスケア|
|産業（industry）||Biotechnology: Biological Products (No Diagnostic Substances)|
Thinking about buying stock in Bridgeline Digital, Seelos Therapeutics, Vistagen Therapeutics, BioLineRx, or Entera Bio? 2021/07/01 12:30:00 Benzinga
NEW YORK , July 1, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BLIN, SEEL, VTGN, BLRX, and ENTX. Full story available on Benzinga.com
Entera Bio to Conduct Conference Call on June 30 to Discuss Phase 2 Results for EB613 Positioned to be the First Oral Bone-Building Agent for the Treatment of Osteoporosis 2021/06/28 19:15:00 Intrado Digital Media
BOSTON and JERUSALEM, June 28, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced it will conduct a conference call to discuss results from its successfully completed Phase 2 clinical trial of EB613 for the treatment of osteoporosis. EB613 is an oral formulation of human parathyroid hormone (1-34), or PTH, and is positioned to be the first oral bone building (anabolic) product to treat osteoporosis patients.
Entera Stock Could More Than Double From Here, Says Analyst 2021/06/25 22:23:29 TipRanks
In the biotech space, big announcements often precede big share price movements; both were on tap for Entera Bio (ENTX) on Wednesday. Entera shares took off after the
Stock with unusually volume activity: Entera Bio Ltd. (NASDAQ:ENTX), Fisker Inc. (NYSE:FSR) 2021/06/24 22:44:19 Stock Equity
Entera Bio Ltd. (NASDAQ:ENTX) with the stream of -6.31% also noticed, India Fisker Inc. (NYSE:FSR) encountered a rapid change of 0.70% in the last hour of Thursdays trading session. Entera The post Stock with unusually volume activity: Entera Bio Ltd. (NASDAQ:ENTX), Fisker Inc. (NYSE:FSR) appeared first on Stocks Equity .
関連キーワード （― 米国株 ENTXW Entera Bio Ltd.）